'Heavenly Hats' Gives Headwear to Cancer Patients

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 9
Volume 15
Issue 9

In 2001, a grandmother with breast cancer inspired Anthony Leanna, then 10 years old, to start the Heavenly Hats Foundation, a nonprofit corporation that provides free headwear to cancer patients nationwide.

GREEN BAY, Wisconsin—In 2001, a grandmother with breast cancer inspired Anthony Leanna, then 10 years old, to start the Heavenly Hats Foundation, a nonprofit corporation that provides free headwear to cancer patients nationwide. "After spending time in hospitals when my grandma had breast cancer, I was able to see all of the patients in the hospital, many without hair, and wanted to do something to help. I knew that if I was in the hospital and had lost my hair, I would want a hat to wear," Mr. Leanna, now 15, says on the foundation's website (www.heavenlyhats.com). His grandmother, he adds, is "doing great."

The hat gathering started with "donation barrels in local stores," Mr. Leanna said. To date, the Foundation has distributed some 90,000 hats to hospitals and clinics around the country and thousands more directly to individuals.

The Foundation is holding its first "National Hat Parade Day" on October 6. The idea is that anyone at a participating school or business who donates $1.00 to the Foundation will be allowed to wear his or her favorite hat that day at school or work.

"It is my dream to have a Heavenly Hats chapter in every state across the United States and eventually in other countries," Mr. Leanna said.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.